Home › NDC Lookup › RxCUI directory › RxCUI 312140

Oxiconazole 10 MG/ML Topical Lotion — RxCUI 312140

RxNorm drug concept · Semantic clinical drug
RxCUI 312140 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI312140
Official nameOxiconazole 10 MG/ML Topical Lotion
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asoxiconazole 1 % Topical Lotion; oxiconazole nitrate 1 % Topical Lotion; oxiconazole (as oxiconazole nitrate) 1 % Topical Lotion
FDA products mapped1
Package NDCs mapped3
Reported Medicaid activity (SDUD)15 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oxiconazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats fungal skin infections — specifically athlete's foot (the itchy, scaly rash between your toes), jock itch (a rash in the groin area), ringworm (a ring-shaped rash on the...
  • What kinds of infections does oxiconazole actually treat?
  • You may start to see improvement before you finish the full course, but it's important to keep using it for the entire recommended period — 2 weeks for ringworm, jock itch, and tin...
  • How long do I need to use it before it starts working?
📖 Read our full Oxiconazole guide →

🕸️ Concept Web — How Oxiconazole 10 MG/ML Topical Lotion Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Oxiconazole 10 MG/ML Topical Lotion RxCUI 312140

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Oxiconazole 32638
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Oxistat 218977
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Oxiconazole Topical Lotion 377916
    • Oxiconazole Topical Product 1160146
    • Oxiconazole Topical Lotion [Oxistat] 365798
    • Oxistat Topical Product 1185759
    • Topical Lotion 316983
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Oxiconazole 10 MG/ML SCDC · 343119
  • Oxiconazole Topical Lotion SCDF · 377916
  • Oxiconazole Topical Product SCDG · 1160146

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 312140 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
62559-0285-06 6 BOTTLE in 1 CARTON (62559-285-06) / 7 mL in 1 BOTTLE Oxistat ANI Pharmaceuticals, Inc. 2022-09-12
62559-0285-30 1 BOTTLE in 1 CARTON (62559-285-30) / 30 mL in 1 BOTTLE Oxistat ANI Pharmaceuticals, Inc. 2022-09-12
62559-0285-60 1 BOTTLE in 1 CARTON (62559-285-60) / 60 mL in 1 BOTTLE Oxistat ANI Pharmaceuticals, Inc. 2022-09-12
Observed labelers: ANI Pharmaceuticals, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$11.3669
Range $11.3669–$11.3669 · middle 50% $11.3669–$11.3669 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.